Evidence map›Paper›PMID 37239926›Full record

ReviewInternational journal of molecular sciences2023

COVID-19-The Shift of Homeostasis into Oncopathology or Chronic Fibrosis in Terms of Female Reproductive System Involvement.

Elena Petersen, Daria Chudakova, Daiana Erdyneeva, Dulamsuren Zorigt, Evgeniya Shabalina, Denis Gudkov, Pavel Karalkin, Igor Reshetov, Ospan A Mynbaev

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elena PetersenMoscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia.ORCID 0000-0002-8150-7553
Daria ChudakovaMoscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia.ORCID 0000-0002-9354-6824
Daiana ErdyneevaMoscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia.ORCID 0000-0003-2279-0157
Dulamsuren ZorigtMoscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia.ORCID 0000-0001-8133-689X
Evgeniya ShabalinaMoscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia.ORCID 0000-0002-8184-7363
Denis GudkovMoscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia.ORCID 0000-0003-2582-1166
Pavel KaralkinP.A. Herzen Moscow Research Institute of Oncology, 125284 Moscow, Russia.ORCID 0000-0002-2838-0776
Igor ReshetovInstitute of Cluster Oncology, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia.ORCID 0000-0002-3888-8004
Ospan A MynbaevMoscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia.ORCID 0000-0002-9309-1938

Funding

Russian Science Foundation 18-15-00391Russian Science Foundation 21-15-00411
6 · The paper itself

Abstract

The COVID-19 pandemic caused by the SARS-CoV-2 coronavirus remains a global public health concern due to the systemic nature of the infection and its long-term consequences, many of which remain to be elucidated. SARS-CoV-2 targets endothelial cells and blood vessels, altering the tissue microenvironment, its secretion, immune-cell subpopulations, the extracellular matrix, and the molecular composition and mechanical properties. The female reproductive system has high regenerative potential, but can accumulate damage, including due to SARS-CoV-2. COVID-19 is profibrotic and can change the tissue microenvironment toward an oncogenic niche. This makes COVID-19 and its consequences one of the potential regulators of a homeostasis shift toward oncopathology and fibrosis in the tissues of the female reproductive system. We are looking at SARS-CoV-2-induced changes at all levels in the female reproductive system.

Indexed as

COVID-19Endothelial CellsFemaleFibrosisGenitalia, FemaleHumansPandemicsSARS-CoV-2COVID-19endometrial cancerfemale reproductive systemmalignant tumorsoncogenic virusesSARS-CoV-2tissue microenvironmenttumor microenvironmentuterine fibrosis

Identifiers

PMID37239926
PMCPMC10217917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.